Improving viral vector safety for gene therapies
Drug Discovery World
AUGUST 21, 2024
Dr Andrea O’Hara, Senior Product Manager at Azenta Life Sciences asks why integration site analysis (ISA) is critical for the safety and efficacy of viral vectors for gene therapy. PCR-based approaches amplify the vector-genome junctions, and the resulting amplicons are sequenced. to 10% in hepatocytes.
59 
Let's personalize your content